SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma.

TPS11588Background: Radiotherapy (RT) and surgical resection achieve local tumor control for most large, high-grade soft tissue sarcomas (STS) of the extremity. However, many patients (pts) subsequ...